‘Positive momentum' for Kromek as government demand grows for specialised hazard detection tools
Kromek has hailed “positive momentum” in its latest results as the company said it had seen growing demand from governments for specialised tools to identify chemical, biological, radiological, and nuclear hazards.
The firm, which has a research and development facility in Huddersfield, saw its revenues lift to £27.1m for the year ended April 30, up from £26.5m a year prior.
Profit before tax landed ahead of expectations for the firm at £2.5m, down from £3.1m a year earlier.
The company said the dip reflected profits of £1.7m from its Advanced Imaging division, which posted a profit of £6.9m a year earlier due to an exceptional contribution from an Enablement Agreement to 2025.
Kromek posted a profit of £0.8m from its CBRN Detection arm, up from a £3.8m loss a year earlier. The firm’s CBRN arm develops products and solutions designed to detect radiological and biological threats.
Dr Arnab Basu, CEO of Kromek, said: "FY 2026 was a year of strong operational and commercial progress for Kromek.
“We delivered increased revenue, with significant underlying growth in Advanced Imaging and further growth in CBRN Detection, reflecting increased delivery on long-term customer programmes, new order wins and the continued expansion of our international distributor network.
“We also made further progress with major OEMs in next-generation medical imaging, secured an initial order under the UK Government's Radiological Nuclear Detection Framework, and continued to invest in manufacturing capability, automation and our intellectual property portfolio.”
During the period, Kromek’s CBRN Detection arm secured an·initial order, worth £1.7m, under the UK Government's Radiological Nuclear Detection Framework for the firm’s nuclear security products.
The company also won eight new distribution agreements signed with partners across Europe, the Middle East and Asia, including signing first agreement in Germany.
In addition, Kromek secured a contract with the Defence Science and Technology Laboratory of the UK Ministry of Defence, worth £250,000, for the development of novel methods of enhancing the detection of biological agents and incidents.
Mr Basu added: "We enter FY 2027 with positive momentum, supported by a healthy order book, an encouraging commercial pipeline and strong engagement with customers across both divisions.
“As demand develops for our Advanced Imaging technologies and government and security customers continue to invest in CBRN detection capabilities, we expect to deliver results in line with market expectations, including significant revenue growth in both divisions, while maintaining disciplined cost control and investment in key growth opportunities.
“Accordingly, the board continues to look forward to the year ahead with confidence."
Kromek added that during the period, it applied for three new patents and had seven patents granted, with the total number of patents now held being in excess of 190.